254 related articles for article (PubMed ID: 33558678)
61. Striatal alcohol cue-reactivity is stronger in male than female problem drinkers.
Kaag AM; Wiers RW; de Vries TJ; Pattij T; Goudriaan AE
Eur J Neurosci; 2019 Aug; 50(3):2264-2273. PubMed ID: 29888821
[TBL] [Abstract][Full Text] [Related]
62. High-dose baclofen attenuates insula activation during anticipatory anxiety in treatment-seeking alcohol dependant individuals: Preliminary findings from a pharmaco-fMRI study.
Morley KC; Logge WB; Fraser I; Morris RW; Baillie AJ; Haber PS
Eur Neuropsychopharmacol; 2021 May; 46():28-36. PubMed ID: 33735709
[TBL] [Abstract][Full Text] [Related]
63. Oral topiramate reduces the consequences of drinking and improves the quality of life of alcohol-dependent individuals: a randomized controlled trial.
Johnson BA; Ait-Daoud N; Akhtar FZ; Ma JZ
Arch Gen Psychiatry; 2004 Sep; 61(9):905-12. PubMed ID: 15351769
[TBL] [Abstract][Full Text] [Related]
64. A double-blind, placebo-controlled trial of topiramate for the treatment of comorbid cocaine and alcohol dependence.
Kampman KM; Pettinati HM; Lynch KG; Spratt K; Wierzbicki MR; O'Brien CP
Drug Alcohol Depend; 2013 Nov; 133(1):94-9. PubMed ID: 23810644
[TBL] [Abstract][Full Text] [Related]
65. Neurobiological correlates of cue-reactivity in alcohol-use disorders: A voxel-wise meta-analysis of fMRI studies.
Zeng J; Yu S; Cao H; Su Y; Dong Z; Yang X
Neurosci Biobehav Rev; 2021 Sep; 128():294-310. PubMed ID: 34171325
[TBL] [Abstract][Full Text] [Related]
66. Post-treatment effects of topiramate on alcohol-related outcomes: A combined analysis of two placebo-controlled trials.
Kranzler HR; Feinn R; Pond T; Hartwell E; Gelernter J; Crist RC; Witkiewitz K
Addict Biol; 2022 Mar; 27(2):e13130. PubMed ID: 35229945
[TBL] [Abstract][Full Text] [Related]
67. Baclofen modulates cardiovascular responses to appetitive cues in treatment-seeking alcohol use disorder individuals.
Logge WB; Baillie AJ; Haber PS; Morley KC
Hum Psychopharmacol; 2020 Mar; 35(2):e2722. PubMed ID: 32045501
[TBL] [Abstract][Full Text] [Related]
68. Intravenous ghrelin administration increases alcohol craving in alcohol-dependent heavy drinkers: a preliminary investigation.
Leggio L; Zywiak WH; Fricchione SR; Edwards SM; de la Monte SM; Swift RM; Kenna GA
Biol Psychiatry; 2014 Nov; 76(9):734-41. PubMed ID: 24775991
[TBL] [Abstract][Full Text] [Related]
69. Cue-elicited craving, thalamic activity, and physiological arousal in adult non-dependent drinkers.
Wang W; Zhornitsky S; Le TM; Dhingra I; Zhang S; Krystal JH; Li CR
J Psychiatr Res; 2019 Sep; 116():74-82. PubMed ID: 31202048
[TBL] [Abstract][Full Text] [Related]
70. The role of the orbitofrontal cortex and the nucleus accumbens for craving in alcohol use disorder.
Bracht T; Soravia L; Moggi F; Stein M; Grieder M; Federspiel A; Tschümperlin R; Batschelet HM; Wiest R; Denier N
Transl Psychiatry; 2021 May; 11(1):267. PubMed ID: 33947835
[TBL] [Abstract][Full Text] [Related]
71. Combined smoking and alcohol cues: Effects on craving, drug-seeking, and consumption.
Motschman CA; Tiffany ST
Alcohol Clin Exp Res; 2021 Sep; 45(9):1864-1876. PubMed ID: 34469584
[TBL] [Abstract][Full Text] [Related]
72. Ibudilast for alcohol use disorder: study protocol for a phase II randomized clinical trial.
Burnette EM; Baskerville WA; Grodin EN; Ray LA
Trials; 2020 Sep; 21(1):779. PubMed ID: 32912290
[TBL] [Abstract][Full Text] [Related]
73. Baclofen-induced Changes in the Resting Brain Modulate Smoking Cue Reactivity: A Double-blind Placebo-controlled Functional Magnetic Resonance Imaging Study in Cigarette Smokers.
Ketcherside A; Jagannathan K; Dolui S; Hager N; Spilka N; Nutor C; Rao H; Franklin T; Wetherill R
Clin Psychopharmacol Neurosci; 2020 May; 18(2):289-302. PubMed ID: 32329309
[TBL] [Abstract][Full Text] [Related]
74. Topiramate treatment of alcohol use disorder in veterans with posttraumatic stress disorder: a randomized controlled pilot trial.
Batki SL; Pennington DL; Lasher B; Neylan TC; Metzler T; Waldrop A; Delucchi K; Herbst E
Alcohol Clin Exp Res; 2014 Aug; 38(8):2169-77. PubMed ID: 25092377
[TBL] [Abstract][Full Text] [Related]
75. Alcohol-related context modulates neural correlates of inhibitory control in alcohol dependent patients: Preliminary data from an fMRI study using an alcohol-related Go/NoGo-task.
Stein M; Steiner L; Fey W; Conring F; Rieger K; Federspiel A; Moggi F
Behav Brain Res; 2021 Feb; 398():112973. PubMed ID: 33157169
[TBL] [Abstract][Full Text] [Related]
76. Corticostriatal and Dopaminergic Response to Beer Flavor with Both fMRI and [(11) C]raclopride Positron Emission Tomography.
Oberlin BG; Dzemidzic M; Harezlak J; Kudela MA; Tran SM; Soeurt CM; Yoder KK; Kareken DA
Alcohol Clin Exp Res; 2016 Sep; 40(9):1865-73. PubMed ID: 27459715
[TBL] [Abstract][Full Text] [Related]
77. Blockade of cue-induced brain activation of abstinent alcoholics by a single administration of amisulpride as measured with fMRI.
Hermann D; Smolka MN; Wrase J; Klein S; Nikitopoulos J; Georgi A; Braus DF; Flor H; Mann K; Heinz A
Alcohol Clin Exp Res; 2006 Aug; 30(8):1349-54. PubMed ID: 16899037
[TBL] [Abstract][Full Text] [Related]
78. Comparing and Combining Topiramate and Aripiprazole on Alcohol-Related Outcomes in a Human Laboratory Study.
Haass-Koffler CL; Goodyear K; Zywiak WH; Leggio L; Kenna GA; Swift RM
Alcohol Alcohol; 2018 May; 53(3):268-276. PubMed ID: 29281033
[TBL] [Abstract][Full Text] [Related]
79. A human laboratory study of the effects of quetiapine on subjective intoxication and alcohol craving.
Ray LA; Chin PF; Heydari A; Miotto K
Psychopharmacology (Berl); 2011 Oct; 217(3):341-51. PubMed ID: 21487653
[TBL] [Abstract][Full Text] [Related]
80. Alcohol craving in the natural environment: Moderating roles of cue exposure, drinking, and alcohol sensitivity.
Kohen CB; Cofresà RU; Bartholow BD; Piasecki TM
Exp Clin Psychopharmacol; 2023 Feb; 31(1):57-71. PubMed ID: 35025586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
